HP
SLXNW

Hartree Partners’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Hartree Partners’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$7.29K Hold
182,355
– – ﹤0.01% 53
2025
Q1 		$14.6K Sell
182,355
-5,145
-3% -$412 0.01% 42
2024
Q4 		$5.63K Hold
187,500
– – ﹤0.01% 57
2024
Q3 		$5.63K Buy
+187,500
New +$5.63K ﹤0.01% 58